Literature DB >> 29193549

Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011.

J Tanaka1, T Akita1, M Ohisa1, K Sakamune1, K Ko1, S Uchida2, M Satake3.   

Abstract

We estimated the total number of undiagnosed HBV and HCV carriers and patients with hepatitis virus-related disease in Japan according to 6 different groups classified by their natural histories during 2011. In 2011, the total number of carriers and patients infected with HBV or HCV was estimated according to 6 groups using government reports and reports from the hepatitis epidemiology research group of The Ministry of Health, Labor and Welfare in Japan. In 2011, the total number of hepatitis virus carriers was estimated to be 2 090 128-2 840 128 in which the estimated number of undiagnosed HCV and HBV carriers was 776 826 (HBV: 481 470; HCV: 295 356). The total number of treated patients, as either inpatients or outpatients, was estimated to be 811588 (HBV: 303 366; HCV: 520 600) in 2011. It is presumed that many carriers shirk consultation for many reasons, such as patients' misunderstanding, lack of awareness and forgetfulness of their positive status. The numbers of infected patients who did not seek treatment increased gradually to 501 714-1 251 714 (HBV: 333 791-483 791; HCV: 167 923-767 923) in 2011. Compared to 2000, the number of undiagnosed carriers was significantly reduced in 2011 probably because of the well-organized, effective national hepatitis virus screening system that has been launched by the Japanese government since 2002. Moreover, the increase in the number of untreated persons who are aware of their positive status shows that more effort should be invested in improving the referral system from screening centres to core hospitals.
© 2017 The Authors. Journal of Viral Hepatitis Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatitis B; hepatitis C; hepatitis virus carriers; undiagnosed carriers and patients in Japan

Mesh:

Year:  2018        PMID: 29193549     DOI: 10.1111/jvh.12828

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  A 79-year-old Woman with Acute Hepatitis B Caused by the Infection of Subgenotype D1 Hepatitis B Virus in Japan: A Case Study.

Authors:  Kosei Hashimoto; Kouichi Miura; Yoshinari Takaoka; Hiroaki Nomoto; Shunji Watanabe; Mamiko Tsukui; Naoki Morimoto; Norio Isoda; Shigeo Nagashima; Masaharu Takahashi; Hiroaki Okamoto; Hironori Yamamoto
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

2.  Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research.

Authors:  Tingting Li; Shu Su; Yong Zhao; Runze Deng; Mingyue Fan; Ruoxi Wang; Manoj Sharma; Huan Zeng
Journal:  Int J Environ Res Public Health       Date:  2019-01-15       Impact factor: 3.390

3.  Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination.

Authors:  Akio Miyasaka; Yuichi Yoshida; Ting Wang; Yasuhiro Takikawa
Journal:  Hum Vaccin Immunother       Date:  2019-07-25       Impact factor: 3.452

Review 4.  Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view.

Authors:  Junko Tanaka; Tomoyuki Akita; Ko Ko; Yoshihiko Miura; Masahiro Satake
Journal:  Hepatol Res       Date:  2019-08-22       Impact factor: 4.288

5.  Estimating the national cost burden of in-hospital needlestick injuries among healthcare workers in Japan.

Authors:  Hiroyuki Kunishima; Emiko Yoshida; Joe Caputo; Hiroshige Mikamo
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

6.  Generation Gap for Screening and Treatment of Hepatitis C Virus in Saga Prefecture, Japan: An Administrative Database Study of 35,625 Subjects.

Authors:  Hiroshi Isoda; Satoshi Oeda; Ayako Takamori; Keiko Sato; Michiaki Okada; Shinji Iwane; Hirokazu Takahashi; Keizo Anzai; Yuichiro Eguchi; Kazuma Fujimoto
Journal:  Intern Med       Date:  2019-09-18       Impact factor: 1.271

7.  Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers.

Authors:  Minami Kikuchi; Motoji Sawabe; Haruyo Aoyagi; Kosho Wakae; Koichi Watashi; Satoru Hattori; Naoto Kawabe; Kentaro Yoshioka; Junko Tanaka; Masamichi Muramatsu; Takaji Wakita; Hideki Aizaki
Journal:  Hepatol Int       Date:  2021-12-02       Impact factor: 9.029

8.  Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older.

Authors:  Yuri Komaki; Yoshinori Ozono; Kenichi Nakamura; Hisayoshi Iwakiri; Satoru Hasuike; Mitsue Sueta; Tadashi Miike; Shojiro Yamamoto; Hirofumi Uto; Kazunori Kusumoto; Toshimasa Ochiai; Junya Kato; Naoto Komada; Kazuo Kuroki; Toshiharu Eto; Masafumi Shigehira; Shuichi Hirono; Kenji Nagata; Hiroshi Kawakami
Journal:  BMC Gastroenterol       Date:  2022-04-28       Impact factor: 2.847

9.  No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity.

Authors:  Takuya Hirosawa; Naoki Morimoto; Kouichi Miura; Toshiyuki Tahara; Toshimitsu Murohisa; Yukishige Okamura; Takashi Sato; Norikatsu Numao; Masato Imai; Shigeo Tano; Kozue Murayama; Hidekazu Kurata; Iwao Ozawa; Yukimura Fukaya; Hiroaki Yoshizumi; Shunji Watanabe; Mamiko Tsukui; Yoshinari Takaoka; Hiroaki Nomoto; Norio Isoda; Hironori Yamamoto
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

10.  Cancer burden and trends in China: A review and comparison with Japan and South Korea.

Authors:  Dianqin Sun; Maomao Cao; He Li; Siyi He; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2020-04       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.